Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002779746 | SCV003756299 | uncertain significance | Inborn genetic diseases | 2021-10-12 | criteria provided, single submitter | clinical testing | The c.37C>G (p.L13V) alteration is located in exon 1 (coding exon 1) of the PKD1 gene. This alteration results from a C to G substitution at nucleotide position 37, causing the leucine (L) at amino acid position 13 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005011200 | SCV005640710 | uncertain significance | Polycystic kidney disease, adult type | 2024-04-25 | criteria provided, single submitter | clinical testing |